Tim Hendrickson
Keine laufenden Positionen mehr
Vermögen: 232 875 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Tim Hendrickson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tim Hendrickson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing | |
| Rochester Christian University | College/University | Undergraduate Degree | |
| THE WESTAIM CORPORATION | Financial Conglomerates | Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TELESTA THERAPEUTICS INC | Pharmaceuticals: Other | Chairman Director/Board Member | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
BioQ Pharma, Inc.
 BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| REGENXBIO INC. | Pharmaceuticals: Major | Director/Board Member | |
| TYME TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ENDO INTERNATIONAL PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| NICOX SA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Operating Officer | |
| Fairleigh Dickinson University | College/University | Masters Business Admin | |
| University of British Columbia | College/University | Masters Business Admin | |
| University of Western Ontario | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin | |
| University of Victoria | College/University | Undergraduate Degree | |
| EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Chief Executive Officer | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VECIMA NETWORKS INC. | Electronics/Appliances | Director of Finance/CFO | |
Healthcare Leadership Council
 Healthcare Leadership Council Medical/Nursing ServicesHealth Services Healthcare Leadership Council operates as a organization focusing on the provision of a healthcare system. The company is headquartered in Washington, DC. | Medical/Nursing Services | Corporate Officer/Principal | |
Association for Accessible Medicines
 Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
| ParkStone Medical Info Systems | Chief Operating Officer | ||
iFire Technology Ltd.
 iFire Technology Ltd. Electronic Production EquipmentElectronic Technology iFire Technology Ltd. engages in electrical manufacturing activities. The company is headquartered in Toronto, Canada. | Electronic Production Equipment | Director of Finance/CFO | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Chairman Director/Board Member Corporate Officer/Principal | |
| NRG Energy Ltd. | Director of Finance/CFO | ||
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Pharmaceuticals: Other | Chief Executive Officer | |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Biotechnology | Director/Board Member | |
Vertice Pharma LLC
 Vertice Pharma LLC Pharmaceuticals: MajorHealth Technology Vertice Pharma LLC operates as a pharmaceuticals company that develops, manufactures, markets, and distributes pharmaceutical products through its operating companies. The company was founded by Donald W. DeGolyer and is headquartered in Berkeley Heights, NJ. | Pharmaceuticals: Major | Founder | |
| Roundtable On Critical Care Policy | Director/Board Member | ||
Vertice Pharma UK Parent Ltd.
 Vertice Pharma UK Parent Ltd. Pharmaceuticals: MajorHealth Technology Vertice Pharma UK Parent Ltd. engages in the activities of a holding company with interest in pharmaceutical industry. The company was founded in 2015 and is headquartered in Berkeley Heights, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Vertice Pharma UK Holdings Ltd.
 Vertice Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Holdings Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in London, UK and was founded in 2015. | Pharmaceuticals: Major | Director/Board Member | |
Vertice Pharma UK Intermediate Ltd.
 Vertice Pharma UK Intermediate Ltd. Financial ConglomeratesFinance Part of Vertice Pharma UK Parent Ltd., Vertice Pharma UK Intermediate Ltd. functions as an investment holding company. The company is based in London, UK and was founded in 2015. | Financial Conglomerates | Director/Board Member | |
| VENUS CONCEPT INC. | Medical Specialties | President | |
Duchesnay USA, Inc.
 Duchesnay USA, Inc. Pharmaceuticals: MajorHealth Technology Duchesnay USA, Inc. operates as a pharmaceutical company. The firm?s products include Bonjesta, Osphena and Diclegis. The company was founded in 2011 and is headquartered in Rosemont, PA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Xevant, Inc.
 Xevant, Inc. Packaged SoftwareTechnology Services Xevant, Inc. is a pharmacy benefits platform that automates and simplifies the process of report building for pbms, tpas, health plans, brokers, and consultants. The company is based in Lehi, UT. The platform infuses real-time automation and alerts throughout the data analysis process, resulting in optimized business processes, reduced operating costs, and improved patient outcomes. Xevant is recognized as one of Modern Healthcare's best places to work and the No. 1 fastest-growing private software company on the 2022 Inc. 5000 list. The company was founded in 2017 by Brandon Newman, who has been the CEO since 2017. | Packaged Software | Director/Board Member | |
| BAUSCH + LOMB CORPORATION | Medical Specialties | Corporate Officer/Principal | |
| LITHA HEALTHCARE GROUP LIMITED | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 27 |
| Kanada | 16 |
| Vereinigtes Königreich | 5 |
| Frankreich | 3 |
| Irland | 2 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 3 |
Operativ
| Director/Board Member | 108 |
| Corporate Officer/Principal | 45 |
| Independent Dir/Board Member | 42 |
| Chairman | 24 |
| Chief Executive Officer | 19 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Laura Brege | 27 |
| Norma Beauchamp | 24 |
| J. Lanthier | 23 |
| Donald DeGolyer | 20 |
| William McDowall Wells | 18 |
| Daniel Tassé | 16 |
| Gregory Gubitz | 12 |
| Yvon Bastien | 11 |
| Hermanth Varghese | 11 |
| Sanjiv Sharma | 10 |
| Rodney Hill | 10 |
| Gilbert Godin | 8 |
| David Spence | 7 |
| John Welborn | 7 |
| Kyle Dempsey | 7 |
- Börse
- Insiders
- Tim Hendrickson
- Unternehmensverbindungen